Medical Oncology

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: A hellenic cooperative oncology group phase III study
pp. 95-107(13)
Authors: Fountzilas, George; Ciuleanu, Elisabeta; Dafni, Urania; Plataniotis, George; Kalogera-Fountzila, Anna; Samantas, Epaminontas; Athanassiou, Eleni; Tzitzikas, John; Ciuleanu, Tudor; Nikolaou, Angelos; Pantelakos, Panayiotis; Zaraboukas, Thomas; Zamboglou, Nikolaos; Daniilidis, John; Ghilezan, Nicolas

Lung cancer in patients with HIV infection and review of the literature
pp. 109-115(7)
Authors: Spano, Jean-Philippe; Massiani, Marie-Ange; Bentata, Michele; Rixe, Olivier; Friard, Sylvie; Bossi, Philippe; Rouges, François; Katlama, Christine; Breau, Jean-Luc; Morere, Jean-Francois; Khayat, David; Couderc, Louis-Jean

Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer
pp. 117-121(5)
Authors: Zidan, Jamal; Keidar, Zohar; Basher, Walid; Israel, Ora

The nuclear oxysterol receptor LXRα is expressed in the normal human breast and in breast cancer
pp. 123-131(9)
Authors: Vigushin, D.; Dong, Y.; Inman, L.; Peyvandi, N.; Alao, J.; Sun, C.; Ali, S.; Niesor, E.; Bentzen, C.; Coombes, R.

Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
pp. 133-138(6)
Authors: Koizumi, Tomonobu; Yoshiike, Fumiaki; Inou, Hitoshi; Hatayama, Orie; Sasabayashi, Mari; Tsushima, Kenji; Yamamoto, Hiroshi; Hayasaka, Muneharu; Kubo, Keishi

Should mammographic screening be done in primary ovarian cancer?: A case control study in turkish women
pp. 139-143(5)
Authors: Ozguroglu, M.; Avci, B.; Turna, H.; Esen, G.; Arun, B.; Çelik, V.; Serdengeçti, S.

Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines
pp. 145-154(10)
Authors: Cross, D.; Reding, D.; Salzman, S.; Zhang, K.; Catalona, W.; Burke, J.; Burmester, J.

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses
pp. 155-165(11)
Authors: Lundqvist, Andreas; Palmborg, Andreas; Bidla, Gawa; Whelan, Mike; Pandha, Hardev; Pisa, Pavel

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer
pp. 167-177(11)
Authors: Khan, Tanweera; Sundin, Anders; Juhlin, Claes; Wilander, Erik; Öberg, Kjell; Eriksson, Barbro

The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patients
pp. 179-185(7)
Authors: Jurišić, V.; Konjević, G.; Jančić-Nedeljkov, R.; Sretenović, M.; Banićević, B.; Colović, M.; Spužić, I.

Enzyme activities controlling adenosine levels in normal and neoplastic tissues
pp. 187-195(9)
Authors: Vannoni, D.; Bernini, A.; Carlucci, F.; Civitelli, S.; Pietro, M.; Leoncini, R.; Rosi, F.; Tabucchi, A.; Tanzini, G.; Marinello, E.

Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats
pp. 197-203(7)
Authors: Orhan, Bulent; Yalcin, Suayib; Nurlu, Gulay; Zeybek, Dilara; Muftuoglu, Sevda

Rituximab-induced tumor progression: Does it really happen?
pp. 205-206(2)
Authors: Ozguroglu, Mustafa; Turna, Hande

Book review
pp. 207-207(1)
Author: Racevskis, Janis

Book review
pp. 209-210(2)
Author: Dutcher, Janice